339 related articles for article (PubMed ID: 31343904)
1. Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.
Choi Y; Lim S; Yoon HY; Kim BS; Kwon IC; Kim K
Expert Opin Drug Deliv; 2019 Aug; 16(8):835-846. PubMed ID: 31343904
[No Abstract] [Full Text] [Related]
2. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
3. Alteration of tumor microenvironment for improved delivery and intratumor distribution of nanocarriers.
Ishida T; Kiwada H
Biol Pharm Bull; 2013; 36(5):692-7. PubMed ID: 23649327
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs.
Choudhury NN; He H
Curr Pharm Biotechnol; 2012 Jun; 13(7):1317-31. PubMed ID: 22201588
[TBL] [Abstract][Full Text] [Related]
5. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
[TBL] [Abstract][Full Text] [Related]
6. Active targeting strategies for anticancer drug nanocarriers.
Basile L; Pignatello R; Passirani C
Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
[TBL] [Abstract][Full Text] [Related]
7. Hydrophobic ion pairing as a strategy to improve drug encapsulation into lipid nanocarriers for the cancer treatment.
Oliveira MS; Goulart GCA; Ferreira LAM; Carneiro G
Expert Opin Drug Deliv; 2017 Aug; 14(8):983-995. PubMed ID: 27892713
[TBL] [Abstract][Full Text] [Related]
8. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Kamath PR; Sunil D
Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
[TBL] [Abstract][Full Text] [Related]
9. Folate-targeted multifunctional amino acid-chitosan nanoparticles for improved cancer therapy.
Gaspar VM; Costa EC; Queiroz JA; Pichon C; Sousa F; Correia IJ
Pharm Res; 2015 Feb; 32(2):562-77. PubMed ID: 25186437
[TBL] [Abstract][Full Text] [Related]
10. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
[TBL] [Abstract][Full Text] [Related]
11. Organic nanocarriers for cancer drug delivery.
López-Dávila V; Seifalian AM; Loizidou M
Curr Opin Pharmacol; 2012 Aug; 12(4):414-9. PubMed ID: 22465543
[TBL] [Abstract][Full Text] [Related]
12. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
13. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
[TBL] [Abstract][Full Text] [Related]
14. Drug and gene co-delivery systems for cancer treatment.
Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
[TBL] [Abstract][Full Text] [Related]
15. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
Yu HP; Aljuffali IA; Fang JY
Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
[TBL] [Abstract][Full Text] [Related]
16. Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer.
Kumar L; Baldi A; Verma S; Utreja P
Pharm Nanotechnol; 2018; 6(2):94-110. PubMed ID: 29866028
[TBL] [Abstract][Full Text] [Related]
17. Nanocarriers in Improving Chemotherapy of Multidrug Resistant Tumors: Key Developments and Perspectives.
Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
Curr Pharm Des; 2017; 23(22):3301-3308. PubMed ID: 28403792
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional Chitosan-Capped Gold Nanoparticles for enhanced cancer chemo-radiotherapy: An invitro study.
Fathy MM; Mohamed FS; Elbialy N; Elshemey WM
Phys Med; 2018 Apr; 48():76-83. PubMed ID: 29728233
[TBL] [Abstract][Full Text] [Related]
19. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
Alshememry AK; El-Tokhy SS; Unsworth LD
Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
[TBL] [Abstract][Full Text] [Related]
20. Chitosan is a potential inhibitor of ovarian cancer: Molecular aspects.
Chamani M; Maleki Dana P; Chaichian S; Moazzami B; Asemi Z
IUBMB Life; 2020 Apr; 72(4):687-697. PubMed ID: 31873986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
